These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 8052878

  • 1. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer.
    Belani CP, Aisner J.
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):79-90. PubMed ID: 8052878
    [Abstract] [Full Text] [Related]

  • 2. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 3. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP.
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [Abstract] [Full Text] [Related]

  • 4. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I.
    Cas Lek Cesk; 2005 Aug; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
    Nguyen NP, Leonardo JM, Karlsson U, Vos P, Bullock L, Thomas P, Lepera P, Ludin A, Chu C, Salehpour M, Jendrasiak G, Sallah S.
    Anticancer Res; 2002 Aug; 22(6B):3429-35. PubMed ID: 12552935
    [Abstract] [Full Text] [Related]

  • 7. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG, Pappalardo A, Russo A, Santini D, Di Rosa C, Di Salvo C, Castorina S, Marletta F, Bellissima G, Palermo N, Scuderi C, Bordonaro R.
    Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
    [Abstract] [Full Text] [Related]

  • 8. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
    Kawahara M.
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
    [Abstract] [Full Text] [Related]

  • 9. Management of unresectable stage III non-small cell lung cancer: the role of combined chemoradiation.
    Penland SK, Socinski MA.
    Semin Radiat Oncol; 2004 Oct; 14(4):326-34. PubMed ID: 15558508
    [Abstract] [Full Text] [Related]

  • 10. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Oct; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 11. Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC).
    De Candis D, Stani SC, Bidoli P, Bedini VA, Potepan P, Navarria P, Aglione S, Bajetta E.
    Am J Clin Oncol; 2003 Jun; 26(3):265-9. PubMed ID: 12796598
    [Abstract] [Full Text] [Related]

  • 12. [The recent progress in chemoradiotherapy of lung cancer].
    Ogawara M, Kawahara M, Furuse K.
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2058-64. PubMed ID: 9388514
    [Abstract] [Full Text] [Related]

  • 13. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
    Socinski MA, Clark JA, Halle J, Steagall A, Kaluzny B, Rosenman JG.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
    [Abstract] [Full Text] [Related]

  • 14. Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer.
    Langer CJ.
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):108-16. PubMed ID: 10210549
    [Abstract] [Full Text] [Related]

  • 15. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL.
    Cancer J Sci Am; 1996 Apr; 2(2):99-105. PubMed ID: 9166507
    [Abstract] [Full Text] [Related]

  • 16. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH, Bao Y, Chen M, Zhang L, Li KX, Xu GC, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776
    [Abstract] [Full Text] [Related]

  • 17. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A, Yamasaki M, Matsuura K, Kajihara T, Nitta T, Awaya H, Arita K, Kashiwado K, Ohashi N.
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [Abstract] [Full Text] [Related]

  • 18. Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
    Choy H, Nabid A, Stea B, Scott C, Roa W, Kleinberg L, Ayoub J, Smith C, Souhami L, Hamburg S, Spanos W, Kreisman H, Boyd AP, Cagnoni PJ, Curran WJ.
    J Clin Oncol; 2005 Sep 01; 23(25):5918-28. PubMed ID: 16135463
    [Abstract] [Full Text] [Related]

  • 19. Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).
    Nishimura Y, Nakagawa K, Takeda K, Tanaka M, Segawa Y, Tsujino K, Negoro S, Fuwa N, Hida T, Kawahara M, Katakami N, Hirokawa K, Yamamoto N, Fukuoka M, Ariyoshi Y.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):786-92. PubMed ID: 17512126
    [Abstract] [Full Text] [Related]

  • 20. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)].
    Eberhardt W.
    Praxis (Bern 1994); 1997 Oct 15; 86(42):1647-53. PubMed ID: 9432686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.